Mucosal Vaccines: Innovations for Respiratory Infections
Received Date: Mar 03, 2025 / Published Date: Mar 31, 2025
Abstract
Mucosal vaccine research focuses on innovative strategies for infectious diseases. Studies explore chitosan nanoparticles enhancing immune response in the gut-associated lymphoid tissue. \textit{Oral influenza vaccine candidates show promise in preclinical trials. Nasal vaccines are under development for respiratory syncytial virus} (RSV). Plant-based systems are being evaluated for cost-effective antigen production. Extracellular vesicles are being explored as novel delivery systems. The microbiome’s influence on vaccine efficacy is a key area of interest.
Citation: Bernasconi L (2025) Mucosal Vaccines: Innovations for Respiratory Infections . J Mucosal Immunol Res 09: 294.
Copyright: 漏 2025 Luca Bernasconi This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 480
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 421
- PDF downloads: 59
